BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$2.69B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.49B |
| 3 |
Corteva
CTVA
|
+$1.57B |
| 4 |
Alibaba
BABA
|
+$1.18B |
| 5 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$2.29B |
| 2 |
Apple
AAPL
|
+$1.42B |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$1.06B |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$957M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$888M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.94% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 13.61% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Industrials | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CALL
Pfizer
PFE
$147B
| $117M | 0.01% |
+2,845,589
| New | +$113M |
|
|
SC
1802
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $117M | 0.01% |
4,880,440
-276,831
| -5% | -$6.16M |
|
1803
Cooper-Standard Automotive
CPS
$553M
| $116M | 0.01% |
2,539,899
+66,366
| +3% | +$3.17M |
|
1804
Addus HomeCare
ADUS
$2.17B
| $116M | 0.01% |
1,551,759
+54,424
| +4% | +$3.76M |
|
|
ACIA
1805
DELISTED
Acacia Communications Inc
ACIA
| $116M | 0.01% |
2,463,663
+456,906
| +23% | +$24M |
|
1806
Ares Management
ARES
$31.5B
| $116M | 0.01% |
4,430,549
+3,747,319
| +548% | +$95.2M |
|
|
USCR
1807
DELISTED
U S Concrete, Inc.
USCR
| $116M | 0.01% |
2,329,667
+26,048
| +1% | +$1.21M |
|
1808
AnaptysBio
ANAB
$1.63B
| $116M | ﹤0.01% |
2,050,390
+242,187
| +13% | +$17.4M |
|
1809
Lyft
LYFT
$6.26B
| $116M | ﹤0.01% |
1,758,948
+343,209
| +24% | +$20.6M |
|
|
PLAN
1810
DELISTED
Anaplan, Inc.
PLAN
| $116M | ﹤0.01% |
2,289,309
+1,132,043
| +98% | +$46.8M |
|
1811
AngioDynamics
ANGO
$622M
| $115M | ﹤0.01% |
5,860,071
+36,718
| +0.6% | +$748K |
|
|
MNR
1812
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $115M | ﹤0.01% |
8,497,554
-132,638
| -2% | -$1.82M |
|
1813
SiriusPoint
SPNT
$2.74B
| $115M | ﹤0.01% |
11,129,124
-97,731
| -0.9% | -$1.05M |
|
|
BMCH
1814
DELISTED
BMC Stock Holdings, Inc
BMCH
| $115M | ﹤0.01% |
5,415,068
+368,188
| +7% | +$7.64M |
|
|
HTO
1815
H2O America
HTO
$2.59B
| $114M | ﹤0.01% |
1,883,177
+71,198
| +4% | +$4.38M |
|
|
APLS
1816
DELISTED
Apellis Pharmaceuticals
APLS
| $114M | ﹤0.01% |
4,502,117
+781,085
| +21% | +$15.9M |
|
1817
Pitney Bowes
PBI
$2.51B
| $114M | ﹤0.01% |
26,608,885
+5,311,931
| +25% | +$28.5M |
|
1818
Marcus & Millichap
MMI
$1.18B
| $114M | ﹤0.01% |
3,688,876
-94,144
| -2% | -$3.42M |
|
1819
Andersons Inc
ANDE
$2.38B
| $114M | ﹤0.01% |
4,177,682
+225,673
| +6% | +$6.73M |
|
1820
Papa John's
PZZA
$979M
| $114M | ﹤0.01% |
2,543,015
-6,535
| -0.3% | -$322K |
|
1821
Veracyte
VCYT
$3.71B
| $114M | ﹤0.01% |
3,987,802
+1,215,062
| +44% | +$30.4M |
|
|
CCI.PRA
1822
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $113M | ﹤0.01% |
94,437
+48,010
| +103% | +$56.6M |
|
1823
Simply Good Foods
SMPL
$989M
| $113M | ﹤0.01% |
4,702,639
+525,409
| +13% | +$11.9M |
|
|
PS
1824
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $113M | ﹤0.01% |
3,726,175
+458,958
| +14% | +$14.7M |
|
1825
Marcus Corp
MCS
$949M
| $113M | ﹤0.01% |
3,417,370
+78,672
| +2% | +$2.89M |
|
Similar funds
BlackRock's Q2 2019 Portfolio in Review
As of Q2 2019, BlackRock held 5,206 positions worth $2.34T, up 4.4% from $2.24T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q2 2019 filing shows 233 new, 2,845 increased, 1,535 reduced and 146 closed positions. Its largest new stake was Dow Inc: 50,959,336 shares worth $2.51B. The largest sale was DuPont de Nemours, an estimated $2.29B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q2 2019 buy was Dow Inc: 50,959,336 shares worth $2.51B.
- BlackRock added most to iShares MSCI EAFE ETF in Q2 2019, an estimated $2.49B increase.
- BlackRock's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $2.29B.
- BlackRock fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $957M.
- BlackRock's ten largest holdings make up 15% of its $2.34T portfolio in Q2 2019.
- BlackRock opened 233 new positions and closed 146 in Q2 2019.
- BlackRock's portfolio value rose 4.4% quarter-over-quarter to $2.34T.
Based on BlackRock's 13F filing for Q2 2019, filed 13 Aug 2019.